Avitron Pharma Private Limited
About Avitron Pharma Private Limited
Data last updated:
Avitron Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 06 January 2023.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2023PTC217764.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rutuja Dinkar Pundkar and Swapnil Vasudeo Sonar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sno. 150To153 Fusioon Park S. Dyaneshwar Ngr Off – 128, Pune, Maharashtra, India – 411018.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.21 Lakh, a growth of 131% compared to the previous year. For the same year it recorded a net profit of ₹13,048 (net margin 2.1%) and EBITDA of ₹13,048 (EBITDA margin 2.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSno. 150To153 Fusioon Park S. Dyaneshwar Ngr Off – 128, Pune, Maharashtra, India – 411018
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Avitron Pharma Private Limited
The main business activity of Avitron Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Avitron Pharma Private Limited FY 2025 filings available
Avitron Pharma Private Limited reported revenue of ₹6.21 Lakh (up 131% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Avitron Pharma Private Limited
Revenue rose 131% in the latest year. EBITDA rose 102% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Avitron Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹13,048 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13,048 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Avitron Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 2.1% | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Avitron Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Avitron Pharma Private Limited
Avitron Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rutuja Dinkar Pundkar | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
| Swapnil Vasudeo Sonar | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
Charges & Borrowings of Avitron Pharma Private Limited
Avitron Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Avitron Pharma Private Limited
Employment history and EPFO contributions of people linked to Avitron Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Avitron Pharma Private Limited
Credit Ratings, Litigation & Regulatory Alerts for Avitron Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Avitron Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Avitron Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Avitron Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Avitron Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avitron Pharma Private Limited
Avitron Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 06 January 2023 (3+ years old) and is registered under CIN U24230PN2023PTC217764.
Avitron Pharma reported revenue of ₹6.21 Lakh for FY 2025 (up 131% YoY).
Avitron Pharma has 2 current directors:
- Rutuja Dinkar Pundkar - Director
- Swapnil Vasudeo Sonar - Director
Avitron Pharma reported a net profit of ₹13,048 (net margin 2.1%) and EBITDA of ₹13,048 (EBITDA margin 2.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Avitron Pharma is U24230PN2023PTC217764. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avitron Pharma was incorporated on 06 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.
The registered office of Avitron Pharma is at Sno. 150To153 Fusioon Park S. Dyaneshwar Ngr Off – 128, Pune, Maharashtra, India – 411018.
Avitron Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Avitron Pharma operates in the chemicals industry, in the manufacturing segment.